While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Chief executive Emma Walmsley said ministers must work with the sector to boost investment amid growing concerns about doing ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Vanguards VEA and VEU exchange trade funds both offer investors exposure to international markets and companies outside of ...

Both drugs are made by Danish pharma giant Novo Nordisk, with Ozempic designed to specifically help patients with diabetes. Wegovy, on the other hand, is formulated specifically for weight loss, but ...

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

FY2025 results were boosted by the successful launch of the MindBody GLP-1 system. Click here to find out why LFVN stock is a ...